We are monitoring the impact of COVID-19 on APAC In-Vitro Toxicology Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 201
Share on
Share on

Asia Pacific In-Vitro Toxicology Testing Market Research Report – Segmented By Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Analysis on Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 201
Pages: 140

APAC In-Vitro Toxicology Testing Market Size (2020 to 2025)

The size of the In-Vitro Toxicology Testing Market in the Asia Pacific is expected to worth USD 7073 Million by 2025 from USD 3336 Million in 2020, growing at a CAGR of 16.22% during the forecast period.

In vitro tests provide information on toxicity cost-effectively and rapidly. Rapid advances in biomedical science should lead to newer and more advanced in vitro testing strategies for characterizing hazards.

Factors contributing to the growth of the In-vitro toxicology testing market in this region include encouraging advanced technologies, resistance to animal testing, inadequate databases to facilitate the use of In-vitro testing methods, and more R&D to determine early stage toxicity. The emergence of CROs for outsourcing research projects related to toxicology, opposition to animal testing leading to the use of alternative methods, the increase in the portfolio of pharmaceutical drugs, and the taking of growing consumers consciousness product safety are also supporting the market growth in APAC.

Additionally, ethical concerns and demand from animal activist groups concerning the use of animals for testing, banning of testing on animals on cosmetics, the support of regulatory bodies for approval In-vitro testing, the low costs associated with in vitro toxicology testing, and advances in vitro methodologies are also favoring the In-vitro toxicology testing market in the Asia Pacific.

Besides, the synergistic relationships between various industry players and the growth of toxicological databases to facilitate in vitro testing methods are expected to provide significant growth opportunities for players operating in this market. Driven by the strong demand for biopharmaceuticals, in vitro toxicology tests are the highest in the pharmaceutical industry. The heavy use of toxicology testing in the pharmacokinetic analysis of new and modified generic pharmaceuticals drives revenue growth from these toxicity testing assays. Besides, the presence of several pending drug candidates should stimulate demand for in vitro toxicology tests.

However, in vitro models' insufficiency to determine immune stimulation and autoimmunity and the predictive ability of in vitro tests compared to in vivo tests may hinder the growth of the market.

This market research report on the Asia Pacific in-vitro toxicology testing market has been segmented and sub-segmented into the following categories:

  • By Product: Assays, Reagents & Labware, Services, and Growth Hormone Therapy
  • By Type: ADME (Absorption, Distribution, Metabolism, and Excretion), Dose and Toxic Substance
  • By Toxicity Endpoints & Tests: Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Skin Sensitization & Irritation, Genotoxicity, Neurotoxicity, Organ Toxicity, and Other Toxicity Endpoints & Tests
  • By Technology: OMICS Technologies, Cell Culture Technology, High-Throughput Technologies, and Molecular Imaging Technologies
  • By Method: In-Silico Methods, Biochemical Assays, Cellular Assays, and Ex-Vivo Models
  • By Industry: Cosmetics and Household Products, Diagnostics, Pharmaceuticals, Food Industry, and Chemicals
  • By Country: The United States, Canada, and Rest of North America

Regional Analysis:

The Asia-Pacific region is expected to experience the fastest growth rate during the forecast period due to government agencies' increased initiatives to encourage acceptance of non-animal test models. Several governments are taking steps to minimize animal-based testing models, develop supportive government policies, and provide funds to support in vitro models. These factors are expected to create plenty of growth opportunities for the market. Additionally, conducting clinical trials in Asian countries such as China, Japan, and India is relatively cost-effective compared to Western countries. Several biopharmaceutical companies perform their drug development procedures in this region.

Key market competitors dominating the Asia Pacific in-vitro toxicology testing market profiled in this report are Covance, Inc. (A subsidiary of LabCorp), Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific SE, General Electric Company, BioReliance, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., Catalent and Cyprotex.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                        

                                5.1.1 Introduction                                           

                                5.1.2 Assays                                       

                                5.1.3 Reagents & Labware                                           

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2 Type                                              

                                5.2.1 Introduction                                           

                                5.2.2 ADME (Absorption, Distribution, Metabolism, and Excretion)                                          

                                5.2.3 Dose                                          

                                5.2.4 Toxic Substance                                    

                5.3 Toxicity Endpoints & Tests                                   

                                5.3.1 Introduction                                           

                                5.3.2 Systemic Toxicity                                  

                                5.3.3 Dermal Toxicity                                     

                                5.3.4 Carcinogenicity                                      

                                5.3.5 Ocular Toxicity                                       

                                5.3.6 Skin Sensitization & Irritation                                          

                                5.3.7 Genotoxicity                                          

                                5.3.8 Neurotoxicity                                         

                                5.3.9 Organ Toxicity                                        

                                5.3.10 Other Toxicity Endpoints & Tests                                

                5.4 Technology                                 

                                5.4.1 Introduction                                           

                                5.4.2 OMICS Technologies                                           

                                5.4.3 Cell Culture Technology                                     

                                5.4.4 High-Throughput Technologies                                      

                                5.4.5 Molecular Imaging Technologies                                   

                5.5 Method                                       

                                5.5.1 Introduction                                           

                                5.5.2 In-Silico Methods                                 

                                5.5.3 Biochemical Assays                                              

                                5.5.4 Cellular Assays                                       

                                5.5.5 Ex-Vivo Models                                     

                5.6 Industry                                       

                                5.6.1 Introduction                                           

                                5.6.2 Cosmetics and Household Products                                             

                                5.6.3 Diagnostics                                              

                                5.6.4 Pharmaceuticals                                   

                                5.6.5 Food Industry                                        

                                5.6.6 Chemicals                                

6. Geographical Analysis                                                                              

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                               

                                6.2 China                                             

                                6.3 India                                              

                                6.4 Japan                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Covance, Inc.  (A subsidiary of LabCorp) (U.S.)                                            

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Bio-Rad Laboratories, Inc. (U.S.)                                        

                8.4 Eurofins Scientific SE (Luxembourg)                                 

                8.5 General Electric Company (U.S.)                                       

                8.6 BioReliance, Inc. (U.S.)                                      

                8.7 Charles River Laboratories International, Inc. (U.S.)                                  

                8.8 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.9 Catalent (U.S.)                                          

                8.10 Cyprotex (U.K.)                                      

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific In-Vitro Toxicology Testing Market, By Region, From 2020 to 2025 (USD Billion)           
  2. Asia-Pacific In-Vitro Toxicology Testing Market, By Product, From 2020 to 2025 (USD Billion)        
  3. Asia-Pacific Assays Market, By Region, From 2020 to 2025 (USD Billion)  
  4. Asia-Pacific Reagents & Labware Market, By Region, From 2020 to 2025 (USD Billion)      
  5. Asia-Pacific Services Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia-Pacific In-Vitro Toxicology Testing Market, By Type, From 2020 to 2025 (USD Billion)  
  7. Asia-Pacific ADME (Absorption, Distribution, Metabolism, and Excretion) Market, By Region, From 2020 to 2025 (USD Billion)           
  8. Asia-Pacific Dose Market, By Region, From 2020 to 2025 (USD Billion)       
  9. Asia-Pacific Toxic Substance Market, By Region, From 2020 to 2025 (USD Billion)
  10. Asia-Pacific In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2020 to 2025 (USD Billion)    
  11. Asia-Pacific Systemic Toxicity Market, By Region, From 2020 to 2025 (USD Billion) 
  12. Asia-Pacific Dermal Toxicity Market, By Region, From 2020 to 2025 (USD Billion) 
  13. Asia-Pacific Carcinogenicity Market, By Region, From 2020 to 2025 (USD Billion) 
  14. Asia-Pacific Ocular Toxicity Market, By Region, From 2020 to 2025 (USD Billion)   
  15. Asia-Pacific Skin Sensitization & Irritation Market, By Region, From 2020 to 2025 (USD Billion)      
  16. Asia-Pacific Genotoxicity Market, By Region, From 2020 to 2025 (USD Billion)      
  17. Asia-Pacific Neurotoxicity Market, By Region, From 2020 to 2025 (USD Billion)     
  18. Asia-Pacific Organ Toxicity Market, By Region, From 2020 to 2025 (USD Billion)   
  19. Asia-Pacific Other Toxicity Endpoints & Tests Market, By Region, From 2020 to 2025 (USD Billion) 
  20. Asia-Pacific In-Vitro Toxicology Testing Market, By Technology, From 2020 to 2025 (USD Billion) 
  21. Asia-Pacific OMICS Technologies Market, By Region, From 2020 to 2025 (USD Billion)      
  22. Asia-Pacific Cell Culture Technology Market, By Region, From 2020 to 2025 (USD Billion)
  23. Asia-Pacific High-Throughput Technologies Market, By Region, From 2020 to 2025 (USD Billion)  
  24. Asia-Pacific Molecular Imaging Technologies Market, By Region, From 2020 to 2025 (USD Billion)
  25. Asia-Pacific In-Vitro Toxicology Testing Market, By Method, From 2020 to 2025 (USD Billion)        
  26. Asia-Pacific In-Silico Methods Market, By Region, From 2020 to 2025 (USD Billion)
  27. Asia-Pacific Biochemical Assays Market, By Region, From 2020 to 2025 (USD Billion)         
  28. Asia-Pacific Cellular Assays Market, By Region, From 2020 to 2025 (USD Billion)  
  29. Asia-Pacific Ex-Vivo Models Market, By Region, From 2020 to 2025 (USD Billion)
  30. Asia-Pacific In-Vitro Toxicology Testing Market, By Industry, From 2020 to 2025 (USD Billion)       
  31. Asia-Pacific Cosmetics and Household Products Market, By Region, From 2020 to 2025 (USD Billion)          
  32. Asia-Pacific Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)         
  33. Asia-Pacific Pharmaceuticals Market, By Region, From 2020 to 2025 (USD Billion)
  34. Asia-Pacific Food Industry Market, By Region, From 2020 to 2025 (USD Billion)    
  35. Asia-Pacific Chemicals Market, By Region, From 2020 to 2025 (USD Billion)
  36. China In-Vitro Toxicology Testing Market, By Product, From 2020 to 2025 (USD Billion)     
  37. China In-Vitro Toxicology Testing Market, By Type, From 2020 to 2025 (USD Billion)          
  38. China In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2020 to 2025 (USD Billion)
  39. China In-Vitro Toxicology Testing Market, By Technology, From 2020 to 2025 (USD Billion)
  40. China In-Vitro Toxicology Testing Market, By Method, From 2020 to 2025 (USD Billion)   
  41. China In-Vitro Toxicology Testing Market, By Industry, From 2020 to 2025 (USD Billion)   
  42. India In-Vitro Toxicology Testing Market, By Product, From 2020 to 2025 (USD Billion)     
  43. India In-Vitro Toxicology Testing Market, By Type, From 2020 to 2025 (USD Billion)           
  44. India In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2020 to 2025 (USD Billion)
  45. India In-Vitro Toxicology Testing Market, By Technology, From 2020 to 2025 (USD Billion) 
  46. India In-Vitro Toxicology Testing Market, By Method, From 2020 to 2025 (USD Billion)    
  47. India In-Vitro Toxicology Testing Market, By Industry, From 2020 to 2025 (USD Billion)     
  48. Japan In-Vitro Toxicology Testing Market, By Product, From 2020 to 2025 (USD Billion)   
  49. Japan In-Vitro Toxicology Testing Market, By Type, From 2020 to 2025 (USD Billion)         
  50. Japan In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2020 to 2025 (USD Billion)
  51. Japan In-Vitro Toxicology Testing Market, By Technology, From 2020 to 2025 (USD Billion)
  52. Japan In-Vitro Toxicology Testing Market, By Method, From 2020 to 2025 (USD Billion)   
  53. Japan In-Vitro Toxicology Testing Market, By Industry, From 2020 to 2025 (USD Billion)  

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample